Therapeutic Plasma Exchange Market Report 2026

Therapeutic Plasma Exchange Market Overview

• Therapeutic Plasma Exchange market size has reached to $1.61 billion in 2025 • Expected to grow to $2.4 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Hematological Disorder Prevalence Fueling The Therapeutic Plasma Exchange Market Growth • Market Trend: Advancements In Automation And Safety Features Accelerating Adoption Of Next-Generation Plasma Exchange Systems • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Therapeutic Plasma Exchange Market?

Therapeutic plasma exchange (TPE) refers to a medical procedure used to treat certain autoimmune diseases and other conditions. During TPE, blood is removed from the body, plasma (the liquid portion of the blood) is separated from the blood cells, and then the blood cells are returned to the body, often after being mixed with a replacement fluid. This process helps remove harmful substances from the blood, such as autoantibodies or toxins, which can contribute to various diseases. The main types of therapeutic plasma exchange are therapeutic plasma exchange (TPE) and double-filtered plasmapheresis (DFPP). Therapeutic Plasma Exchange (TPE) is a medical procedure that removes plasma from the blood and replaces it with a replacement fluid, allowing for the elimination of harmful substances or excess components. This procedure is used for several indications, such as neurological disorders, hematological disorders, renal disorders, metabolic disorders, and others. Various technologies are utilized, including centrifugation and membrane separation, which are used by different end users, mainly blood collection centers, hospitals and clinics, transfusion centers, and others.

What Is The Therapeutic Plasma Exchange Market Growth Forecast?

The therapeutic plasma exchange market size is expected to see strong growth in the next few years. It will grow to $2.4 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to growing demand for advanced autoimmune therapies, increasing adoption of membrane separation technology, expansion of outpatient apheresis services, rising investment in blood purification technologies, higher focus on personalized immunological treatments. Major trends in the forecast period include increasing adoption of automated plasma exchange systems, rising use of tpe in neurological disorders, growing demand for high-efficiency separation technologies, expansion of hospital-based apheresis units, enhanced focus on treatment safety and monitoring.

Global Therapeutic Plasma Exchange Market Segmentation

1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP) 2) By Indication: Neurological Disorders, Hematological Disorders, Renal Disorders, Metabolic Disorders, Other Indications 3) By Technology: Centrifugation, Membrane Separation 4) By End User: Blood Collection Centers, Hospitals And Clinics, Transfusion Centers, Other End Users Subsegments: 1) By Therapeutic Plasma Exchange (TPE): Manual TPE, Automated TPE 2) By Double Filtered Plasmapheresis (DFPP): Single-Stage DFPP, Multi-Stage DFPP

What Is The Driver Of The Therapeutic Plasma Exchange Market?

The high prevalence of hematological disorders is expected to propel the growth of the therapeutic plasma exchange market going forward. Hematological disorders, also known as blood disorders, refer to medical conditions that affect the blood and blood-forming tissues, including the bone marrow, lymph nodes, and spleen. Hematological disorders are rising due to factors including genetic predispositions, environmental influences, and lifestyle changes. Therapeutic plasma exchange (TPE) is utilized in hematological disorders to remove pathogenic substances from the plasma, such as autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, thereby mitigating disease severity and improving patient outcomes. For instance, in July 2024, according to Cancer Research UK, a UK-based charity, the average number of new Hodgkin lymphoma cases per year in the UK is expected to increase from approximately 2,400 cases in 2023-2025 to around 2,900 cases in 2038-2040. Therefore, the high prevalence of hematological disorders is driving the growth of the therapeutic plasma exchange industry.

Key Players In The Global Therapeutic Plasma Exchange Market

Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Octapharma AG, Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc.

Global Therapeutic Plasma Exchange Market Trends and Insights

Major companies operating in the therapeutic plasma exchange market are focusing on advancing automation, improving device safety and enhancing system efficiency to boost clinical adoption and streamline workflows. Automation refers to relying on systems and technology to carry out tasks automatically without constant human control. For instance, in November 2024, Terumo BCT, a US-based medical device company, launched software update V12.1 for its flagship Spectra Optia Apheresis System, which enhances usability, strengthens cybersecurity and improves workflow including automatic pump pause during single needle exchange and alarm mitigation. The system supports therapeutic plasma exchange with a mean plasma removal efficiency of 87 %, minimal extracorporeal volume (141 mL), and just 1.0 % median platelet loss This trend toward refined automation and device safety increases TPE uptake in hospitals and specialty clinics; however, high capital cost and need for trained personnel still limit adoption in resource constrained settings.

What Are Latest Mergers And Acquisitions In The Therapeutic Plasma Exchange Market?

In October 2025, Accord Plasma B.V., a Netherlands-based provider of plasma-derived medicines and large-scale plasma fractionation services, acquired Prothya Biosolutions Belgium BV for an undisclosed amount. With this acquisition, Accord Plasma strengthens its global plasma therapy infrastructure by integrating Prothya’s European expertise to expand production capacity and improve access to life-saving plasma-derived medicinal products across multiple regions. Prothya Biosolutions is a Belgium-based provider of plasma fractionation services, operating major manufacturing facilities and plasma collection centers that supply essential plasma-derived therapies.

Regional Outlook

North America was the largest region in the therapeutic plasma exchange market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Therapeutic Plasma Exchange Market?

The therapeutic plasma exchange market consists of revenues earned by entities by providing services such as patient evaluation, treatment planning, medical monitoring, and plasma separation. The market value includes the value of related goods sold by the service provider or included within the service offering. The therapeutic plasma exchange market also includes the sale of plasma separators, replacement fluids, anticoagulants, catheters and access devices, disposable consumables, and monitoring equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Therapeutic Plasma Exchange Market Report 2026?

The therapeutic plasma exchange market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic plasma exchange industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.